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Although, the suprachiasmatic nucleus (SCN) of the hypothalamus acts as the central
clock in mammals, the circadian expression of clock genes has been demonstrated
not only in the SCN, but also in peripheral tissues and brain regions outside the SCN.
However, the physiological roles of extra-SCN circadian clocks in the brain remain
largely elusive. In response, we generated Nkx2.1-Bmal1−/− mice in which Bmal1, an
essential clock component, was genetically deleted specifically in the ventral forebrain,
including the preoptic area, nucleus of the diagonal band, and most of the hypothalamus
except the SCN. In these mice, as expected, PER2::LUC oscillation was drastically
attenuated in the explants of mediobasal hypothalamus, whereas it was maintained in
those of the SCN. Although, Nkx2.1-Bmal1−/− mice were rhythmic and nocturnal, they
showed altered patterns of locomotor activity during the night in a 12:12-h light:dark
cycle and during subjective night in constant darkness. Control mice were more active
during the first half than the second half of the dark phase or subjective night, whereas
Nkx2.1-Bmal1−/− mice showed the opposite pattern of locomotor activity. Temporal
patterns of sleep-wakefulness and feeding also changed accordingly. Such results
suggest that along with mechanisms in the SCN, local Bmal1–dependent clocks in
the ventral forebrain are critical for generating precise temporal patterns of circadian
behaviors.
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INTRODUCTION
The circadian oscillator in the suprachiasmatic nucleus (SCN) of the hypothalamus is the central
pacemaker in mammals, orchestrating multiple circadian rhythms in organisms (Reppert and
Weaver, 2002; Dibner et al., 2010). Each SCN cell has an individual cellular clock driven by
autoregulatory transcriptional and translational feedback loops (TTFLs) of clock genes. Notably,
such cellular clocks also appear in many peripheral tissues and brain regions outside the SCN
(Balsalobre et al., 1998; Yamazaki et al., 2000; Yagita et al., 2001; Abe et al., 2002; Yoo et al., 2004;
Guilding et al., 2009; Dibner et al., 2010). Cell type-specific manipulations of clock genes have
clarified the roles of peripheral circadian clocks in a variety of tissues (McDearmon et al., 2006;
Storch et al., 2007; Lamia et al., 2008; Westgate et al., 2008; Dibner et al., 2010; Marcheva et al.,
2010; Sadacca et al., 2011; Fustin et al., 2012; Paschos et al., 2012; Nguyen et al., 2013; Gibbs et al.,
2014; Jacobi et al., 2015; Xie et al., 2015; Dudek et al., 2016; Xu et al., 2016). By contrast, knowledge
of the physiological roles of brain clocks in extra-SCN regions remains limited (Roybal et al., 2007;
Mukherjee et al., 2010; Mieda and Sakurai, 2011; Spencer et al., 2013; Yu et al., 2014; Nakano et al.,
2016; Orozco-Solis et al., 2016; Shimizu et al., 2016).
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The hypothalamus plays a pivotal role in homeostasis and
in controlling multiple bodily functions that exhibit circadian
fluctuations, including sleep and wakefulness, body temperature,
food intake, and autonomic nervous and endocrine systems. In
addition, local brain clocks have been reported in multiple nuclei
of the hypothalamus (Abe et al., 2002;Mieda et al., 2006; Guilding
et al., 2009; Moriya et al., 2009; Yu et al., 2014; Orozco-Solis et al.,
2016). Therefore, it is especially intriguing to pinpoint the roles
of extra-SCN brain clocks in the hypothalamus.
To genetically dissect the roles of SCN and extra-SCN
clocks, we used mice in which the expression of Cre
recombinase was restricted to the hypothalamus outside the
SCN. We focused on the developmental regulatory genes
involved in the patterning of the neuroepithelium, which are
often expressed in domains that give rise to certain brain
regions and nuclei in adults. Nkx2.1 is a good candidate
because its expression affects a domain that generates the
posteroventral hypothalamus, yet is devoid of the Lhx1-
positive domain that differentiates into the SCN and its
adjacent structures (Puelles and Rubenstein, 2003; Shimogori
et al., 2010). Along with the neuroepithelial domain that
gives rise to the posteroventral hypothalamus, Nkx2.1 is also
expressed developmentally in the medial ganglionic eminence
(MGE) and anterior entopeduncular area (AEP) in the ventral
forebrain, from which γ-aminobutyric acid (GABA) neurons
originate and migrate into the cerebral cortex and basal
ganglia, including the striatum and globus pallidus (Puelles and
Rubenstein, 2003; Kessaris et al., 2006). The MGE and AEP
also generate oligodendrocyte progenitors in developing cortical
and subcortical structures, although those cells decline to a very
small fraction of all oligodendrocytes in most parts of the adult
forebrain (Kessaris et al., 2006).
In our study, we generated mice in which Bmal1, an essential
transcription factor of the TTFL, was deleted specifically in
cells marked by the developmental expression of Nkx2.1. We
demonstrated that although the mice maintained nocturnality
and a normal free-running period of behavioral rhythm driven
by the intact SCN, the temporal patterns of their nocturnal
locomotor activity, sleep-wakefulness cycle, and food intake were
impaired.
METHODS
Animals
To generate Nkx2.1-Bmal1−/− mice (Nkx2.1-Cre;Bmal1f l/−),
Nkx2.1-Cre mice (N > 7 backcrossed to C57BL/6J; Kessaris
et al., 2006) were mated with mice carrying a conditional Bmal1
allele (Bmal1f l; Storch et al., 2007) (N > 7 backcrossed to
C57BL/6J, The Jackson Laboratory #007668), as well as with
mice carrying a null Bmal1 allele (Bmal1−) generated from
Bmal1f l mice (Mieda and Sakurai, 2011). Nkx2.1-Bmal1−/− and
control mice were further mated with Per2::Luc reporter mice
(Yoo et al., 2004) in order to obtain Nkx2.1-Bmal1−/−;Per2::Luc
(Nkx2.1-Cre;Bmal1fl/−;Per2::Luc) and Control;Per2::Luc
(Bmal1f l/−;Per2::Luc) mice. Mice were maintained under a strict
12-h light:dark (LD) cycle in a temperature- and humidity-
controlled room and fed ad libitum. All experimental procedures
involving animals were approved by the respective animal
care and use committee of Kanazawa University and were in
accordance with the guidelines of the National Institutes of
Health.
Histological Study
To examine the specificity of Cre-mediated recombination,
Nkx2.1-Cre mice were crossed with Rosa26R-lacZ reporter mice
(Jackson Laboratory #003474) (Soriano, 1999). Animals were
sacrificed by transcardial perfusion with PBS followed by 4%
paraformaldehyde fixative. Serial coronal brain sections 30 µm
thick were collected in four series, one of which was further
stained by β-galactosidase enzymatic labeling as previously
described (Kessaris et al., 2006). Immunostaining was performed
as previously reported (Mieda et al., 2015) with rabbit anti-
BMAL1 (Novus Biologicals, 1:10,000), biotinylated anti-rabbit
antibody (Vector Labs, 1:500), and the Vectastain ABC kit
(Vector Labs).
Bioluminescence Measurement
Male Nkx2.1-Bmal1−/−;Per2::Luc (n = 6) and control;Per2::Luc
mice (Bmal1fl/−;Per2::Luc; n = 5), aged 17–19 weeks, were
housed in LD before sampling. PER2::LUC bioluminescence
in SCN tissue was measured with a photomultiplier tube
(Atto, Kronos Dio) at 10-min intervals with an exposure time
of 1min. Coronal SCN slices of 300 µm were made with
a vibratome (Leica, Vi1000S) at approximately ZT8–10. The
SCN tissue was dissected at the midrostrocaudal region, and
a paired SCN was cultured on a Millicell-CM culture insert
(Millipore), as previously described (Mieda et al., 2015). Bilateral
MBH explants containing the dorsomedial (DMH), ventromedial
(VMH), and arcuate (Arc) nuclei of the hypothalamus, as
well as the median eminence (ME) and pars tuberalis (PT)
(Guilding et al., 2009) were cultured similarly to the SCN explant.
Recorded values were detrended by subtracting 24-h moving
average values and were smoothened with a 5-point moving
average method. Because luminescence from the SCN of Nkx2.1-
Bmal1−/−;Per2::Luc mice was weak and its waveform was noisy,
the middle of the time points crossing value 0 upward and
downward were defined as acrophases, and the intervals between
two adjacent acrophases were calculated for the periods. The
average of periods of initial three cycles was calculated for each
explant.
Measurements of Locomotor Activity and
Food Intake
Male Nkx2.1-Bmal1−/− (Nkx2.1-Cre;Bmal1f l/− ; n = 11) and
control (Bmal1f l/− and Nkx2.1-Cre;Bmal1+/fl; n = 8 and 6,
respectively) mice, aged 9–15 weeks, were housed individually
in cages placed in a light-tight chamber with a light intensity
of ∼50 lux. Spontaneous locomotor activity and food intake
were recorded by infrared motion sensors and food intake
monitor (O’Hara) in 10-min bins. Actogram, activity profile,
and χ2 periodogram analyses were performed using ClockLab
(Actimetrics). The free-running period was measured by
periodogram for Days 5–21 in constant darkness (DD).
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Sleep Recordings
This study used male Nkx2.1-Bmal1−/− (Nkx2.1-Cre;Bmal1fl/−;
n = 4) and control (Bmal1fl/− and Nkx2.1-Cre;Bmal1+/fl;
n = 3 for each genotype; i.e., 6 control mice in total) mice,
aged 17–21 weeks. These mice were different from those
used for measurements of locomotor activity and food intake.
The implantation of an electroencephalogrammic (EEG) and
electromyographic (EMG) electrode was performed as described
previously (Sasaki et al., 2011). Following surgery, all animals
were housed individually for a recovery period of at least 14
days, after which EEG-EMG recordings were performed on
3 consecutive days in LD. EEG-EMG data were analyzed as
previously described (Sasaki et al., 2011).
Statistics
All results are expressed as the mean ± SEM. Comparisons
between individuals were analyzed by a two-tailed Student’s
t-test. In Figure S1, an one-way repeated measure ANOVA was
performed, followed by a Tukey-HSD post-hoc analysis. When
appropriate, data were analyzed by a two-way repeated measure
ANOVA, followed by a Tukey-HSD post-hoc test.
RESULTS
Cre-Mediated Recombination in the
Hypothalamus of Nkx2.1-Cre Mice
According to the prosomeric model (Puelles and Rubenstein,
2003), the SCN and its adjacent areas develop from a field dorsal
to the anterior basal floor of the secondary prosencephalon,
which generatesmost areas of the hypothalamus and is delineated
by the expression of the homeodomain transcription factor
Nkx2.1. Therefore, we examinedNkx2.1-Cremice (Kessaris et al.,
2006) as a candidate Cre driver, in which Cre is expressed
specifically in the hypothalamus but not the SCN. To localize
cells with Cre-mediated recombination, Nkx2.1-Cre mice were
crossed with Rosa26R-lacZ reporter mice, which expressed β-
Galctosidase (βGal) after the Cre-mediated deletion of a loxP-
flanked transcriptional blocker (Soriano, 1999). We mapped
βGal+ cells in the entire brain of adult mice (Figure 1).
Prominent βGal expression was observed in the medial septum,
nucleus of the diagonal band (Figure 1A), medial preoptic
area (Figures 1B,G), and most areas of the hypothalamus:
the ventromedial (VMH), dorsomedial (DMH), arcuate (Arc)
(Figures 1D,J), mammillary nuclei (MN) (Figure 1E), and the
lateral hypothalamic area (LHA) at the rostrocaudal level of
and posterior to the VMH (Figure 1D). Notably, the SCN,
PVH, and adjacent regions were nearly devoid of βGal+ cells
(Figures 1C,I). Moreover, βGal expression was detected in cells
scattered in the cerebral cortex (Figure 1K), striatum, and globus
pallidus (Figure 1H), which were likely GABAergic neurons
originated from the Nkx2.1+ MGE and AEP. Such expression
was entirely consistent with the developmental expression of
Cre recombinase in Nkx2.1-Cre mice (Kessaris et al., 2006). We
also detected several βGal+ cells in the dorsal raphe nucleus
(Figures 1F,L). Altogether, Nkx2.1-Cre mice may be useful in
revealing the roles of extra-SCN clocks in the hypothalamus.
FIGURE 1 | Distribution of cells with Cre-mediated recombination in Nkx2.1-Cre mice crossed with Rosa26R-lacZ reporter mice. Coronal sections from
the olfactory bulb to medulla were stained by β-galactosidase enzymatic labeling. (A–F) Representative images with positive cells. (G–L) Magnified images of regions
in (B–F). Scale bars, 1 mm for (A–F); 200 µm for (G–L). ac, anterior commissure; 3v, Arc, arcuate hypothalamic nucleus; Aq, aqueduct; Ctx, cerebral cortex; DB,
diagonal band; DMH, dorsomedial hypothalamic nucleus; DRN, dorsal raphe nucleus; LGP, lateral globus pallidus; LH, lateral hypothalamus; Me, medial eminence;
MN, mammillary nuclei; POA, preoptic area; SCN, suprachiasmatic nucleus; Str, striatum; VMH, ventromedial hypothalamic nucleus (Paxinos and Franklin, 2001).
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PER2::LUC Oscillation Attenuated in the
Mediobasal Hypothalamus of
Nkx2.1-Bmal1−/− Mice
We generated mice without the Bmal1 gene in the hypothalamus,
except for in the SCN, by breeding Nkx2.1-Cre mice with mice
carrying floxed Bmal1 alleles (Bmal1f l; Storch et al., 2007). To
improve the efficiency of Bmal1f l allele deletion, we generated
Nkx2.1-Cre;Bmal1f l/− mice to have one floxed and one null
allele of the Bmal1 gene (Mieda and Sakurai, 2011), hereafter
designated as Nkx2.1-Bmal1−/− mice. We first confirmed in
these mice that BMAL1 expression was drastically reduced in
the ventral forebrain, including the Arc, VMH, and the DMH,
but not in the SCN and adjacent regions (Figure 2A). Before
analyzing their behavior in detail, we further crossed Nkx2.1-
Cre mice with mice carrying the PER2::LUC reporter (Yoo
et al., 2004) to confirm ex vivo that circadian clocks in the
mediobasal hypothalamus (MBH; Guilding et al., 2009) were
functionally attenuated inNkx2.1-Bmal1−/−mice. Coronal slices
were prepared from adult mice, and PER2::LUC oscillation
in the SCN of Nkx2.1-Bmal1−/− mice was similar to that
of control mice (amplitude: 6002 ± 435 vs. 5872 ± 559, p
= 0.857; Figure 2B). By contrast, PER2::LUC oscillation in
the MBH of Nkx2.1-Bmal1−/− mice was far less robust and
unstable with reduced amplitude (amplitude: 202 ± 24 vs. 482
± 113, p = 0.018; Figure 2C). The values of period and first
acrophase of PER2::LUC oscillation in control explants were
similar to those reported previously in both the SCN and
MBH (Figures 2D–F; Yoo et al., 2004; Guilding et al., 2009).
Interestingly, the first acrophase of PER2::LUC oscillation in the
MBH occurred earlier in Nkx2.1-Bmal1−/− mice than control
mice. Thus, local circadian clocks in the MBH were severely
impaired in Nkx2.1-Bmal1−/− mice, whereas the SCN central
clock remained normal.
Altered Temporal Pattern of Nocturnal
Locomotor Activity in Nkx2.1-Bmal1−/−
Mice
We next measured the circadian rhythm of spontaneous
locomotor activity in Nkx2.1-Bmal1−/− (Nkx2.1-Cre;Bmal1f l/−)
mice. We examined two strains of mice, Bmal1f l/− and Nkx2.1-
Cre;Bmal1+/fl, as control mice. All three lines demonstrated a
clear nocturnal pattern of behavioral rhythm in LD (Figure 3
and Figure S1). The free-running periods of behavioral rhythm
in DD were similar between Nkx2.1-Bmal1−/− and two strains
of control mice (Figure 3C and Figure S1C). However, the
activity was substantially reduced in Nkx2.1-Bmal1−/− and
Nkx2.1-Cre;Bmal1+/fl mice compared to that of Bmal1f l/− mice
in LD (Figures S1A,E). We observed a similar attenuation of
activity during the subjective night in those two strains free-
running in DD (Figures S1A,D,E). Such results suggest that
having the Nkx2.1-Cre allele caused a reduction of nocturnal
activity regardless of the expression of Bmal1. Notably, the
temporal pattern of nocturnal locomotor activity was clearly
altered in Nkx2.1-Bmal1−/− mice compared to both control
strains (Figure S1A). Such an alteration was more obvious
when daily activity profiles were adjusted in accordance with
activity levels (Figure 3B and Figure S1B). In both LD and
DD, control mice were more active during the first than the
second half of the dark phase or subjective night. By contrast,
Nkx2.1-Bmal1−/− mice were more active during the second
half of the dark phase or subjective night. The amplitude of
the free-running rhythm of behavior, for which we calculated
Qp values by periodogram analyses, was significantly lower in
Nkx2.1-Bmal1−/− mice than in control mice (Figure 3D and
Figure S1D). Thus, Nkx2.1-Bmal1−/− mice remained nocturnal,
but did not maintain the precise temporal pattern of nocturnal
activity. Because the function of SCN remained normal in those
mice, peripheral circadian clocks in the extra-SCN hypothalamus
might play a role in delineating the activity profile during the dark
phase and subjective night.
Altered Temporal Sleep-Wakefulness
Pattern Parallel to Locomotor Activity in
Nkx2.1-Bmal1−/− Mice
We also examined whether the temporal pattern of daily sleep-
wakefulness was altered in Nkx2.1-Bmal1−/− mice. As expected,
Nkx2.1-Bmal1−/− mice remained nocturnal, but the hourly
patterns of wakefulness, NREM sleep, and REM sleep were all
altered similarly to that of locomotor activity (Figure 4). Time
spent in wakefulness during 24-h of day or during the 12-h dark
phase were significantly reduced (whole day: 722.1 ± 10.7 vs.
654.6 ± 21.8m, p = 0.015; dark phase: 505.1 ± 7.8 vs. 455.0 ±
21.6m, p= 0.034), while those in NREM sleep were significantly
increased in Nkx2.1-Bmal1−/− mice (whole day: 642.3± 10.5 vs.
701.5 ± 25.9m, p = 0.041; dark phase: 200.7 ± 7.5 vs. 249.4 ±
20.9m, p= 0.034).
Altered Temporal Pattern of Nighttime
Food Intake in Nkx2.1-Bmal1−/− Mice
We further examined the hourly food intake of Nkx2.1-
Bmal1−/− mice. As with the patterns of locomotor activity and
sleep-wakefulness, the temporal pattern of food intake during
the dark phase was altered in Nkx2.1-Bmal1−/− mice (Figure 5).
Daily food intake according to body weight did not differ between
control and Nkx2.1-Bmal1−/− mice (0.119 ± 0.003 vs. 0.119 ±
0.004 g/g body weight, p= 0.960). Intriguingly, food intake in the
light phase was significantly increased in Nkx2.1-Bmal1−/− mice
compared to control mice (0.024 ± 0.002 vs. 0.017 ± 0.001 g/g
body weight, p = 0.002), especially in the second half of the light
phase. This increase might be correlated with a similar increase of
locomotor activity in the latter half of the light phase (Figure 3A).
As such, locomotor activity, sleep-wakefulness, and food intake
demonstrated similar changes in their temporal patterns during
the night in Nkx2.1-Bmal1−/− mice.
DISCUSSION
We demonstrated that the SCN central clock alone cannot
precisely delineate the locomotor activity pattern in the dark
phase. The SCN grantsmice nocturnality and roughly determines
when they are active, whereas Bmal1-dependent local clocks in
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FIGURE 2 | PER2::LUC oscillation is attenuated in the mediobasal hypothalamus but not in the SCN of Nkx2.1-Bmal1−/− mice. (A) BMAL1 expression in
the SCN and mediobasal hypothalamus (MBH) of control and Nkx2.1-Bmal1−/− mice. Coronal brain sections were immunostained for BMAL1. The locations of the
(Continued)
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FIGURE 2 | Continued
magnified images are indicated by rectangles in the low-power images. Scale bars, 200 µm. (B,C) Representative circadian rhythm of PER2::LUC in slices of the SCN
(B) and MBH (C) of control and Nkx2.1-Bmal1−/− mice housed in LD. Mean amplitudes of PER2::LUC oscillation are shown on the right. Definition of amplitude was
demonstrated by green dotted lines in (B,C). (D–F) Mean periods (D) and first acrophases (E,F) of PER2::LUC oscillation. Because PER2::LUC expression in the MBH
was reported to be significantly correlated with time of cull (Guilding et al., 2009), the first acrophases were also expressed in hours after cull (F). Two-way repeated
measures ANOVAs revealed statistical significances in the effect of brain region for period [F (1, 8) = 17.16, p = 0.003], in the effects of genotype [F (1, 8) = 619.19, p <
0.001] and region [F (1, 8) = 230.96, p < 0.001], as well as in the interaction between genotype and region [F (1, 8) = 339.05, p < 0.001] for first acrophase (projected
ZT), and in the effects of genotype [F (1, 8) = 6.92, p = 0.030] and region [F (1, 8) = 22.27, p = 0.002] for first acrophase (hours after cull). Values are mean ± SEM.
*p < 0.05; ***p < 0.001; comparison between genotypes by a Tukey-HSD post-hoc. n = 5 for control;Per2::Luc, n = 6 for Nkx2.1-Bmal1−/−;Per2::Luc mice.
FIGURE 3 | Temporal pattern of nocturnal locomotor activity is altered in Nkx2.1-Bmal1−/−. (A) Representative locomotor activity of control and
Nkx2.1-Bmal1−/− mice. Animals were initially housed in 12:12-h light/dark (LD) conditions and later transferred to constant darkness (DD). Gray shading indicates
when lights were off. (B) Daily profile of locomotor activity in LD or DD. Activity counts are expressed as percentage of daily total. (C) Relative activity during 12-h light
phase (Light) and 12-h dark phase (Dark). No significant difference was detected between genotypes. (D,E) Mean free-running period and amplitude (Qp values of
periodogram) in DD. Values for activity in DD were calculated for data on Days 5–19 in DD. Values are mean ± SEM. n = 14 for control, n = 11 for Nkx2.1-Bmal1−/−
mice. ***p < 0.001 by a two-tailed Student’s t-test.
regions defined by developmental Nkx2.1-Cre expression might
fine-tune the temporal pattern of nocturnal activity.
A remarkable feature of Nkx2.1-Cre mice in our study was
that Cre expression occurred in most of the hypothalamus, but
not in the SCN or its adjacent areas. Such a feature made
this Cre driver line suitable for studying local circadian clocks
in the hypothalamus without affecting the central clock in
the SCN. During development, the SCN and PVH originate
from a region immediately dorsal to an area marked by the
expression of Nkx2.1 and that generates many hypothalamic
structures, including the VMH, DMH, ARC, and MN (Puelles
and Rubenstein, 2003; Shimogori et al., 2010). In addition to
the hypothalamus, Nkx2.1 is developmentally expressed in the
AEP and MGE, from which inhibitory neurons in the cortex and
basal ganglia originate (Puelles and Rubenstein, 2003; Kessaris
et al., 2006). Therefore, the distribution of βGal+ cells in adult
Nkx2.1-Cre;Rosa26R-lacZmicematchedwell with developmental
Nkx2.1 expression, except for those in the DRN, which might be
due to an ectopic expression of Cre in Nkx2.1-Cre mice (Puelles
and Rubenstein, 2003; Kessaris et al., 2006; Shimogori et al.,
2010).
In contrast to those addressing peripheral clocks in peripheral
organs, a limited number of reports address what local brain
clocks do in the regulation of behavior and physiology.
Dudley et al. initially reported that the lack of NPAS2,
a paralog of CLOCK expressed in the forebrain, altered
temporal patterns of locomotor activity and sleep-wakefulness
in the active phase, meaning that a brief break in circadian
locomotor activity beginning midway through the active
phase was attenuated (Dudley et al., 2003). Pioneered by
McClung et al. the contribution of local clocks in the ventral
tegmental area and nucleus accumbens, which constitute
the mesolimbic dopaminergic pathway, in mood regulation
has been well-characterized (McClung et al., 2005; Roybal
et al., 2007; Mukherjee et al., 2010; Spencer et al., 2013;
Chung et al., 2014). More recently, Shimizu et al. reported
that the suprachiasmatic nucleus circadian oscillatory protein
(SCOP) mediates the circadian regulation of long-term memory
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FIGURE 4 | Temporal pattern of sleep-wakefulness during the dark phase is altered in Nkx2.1-Bmal1−/ − mice. (A–C) Hourly plots of time spent in
wakefulness (A), NREM sleep (B), or REM sleep (C) in LD. (D–F) Time spent in wakefulness (D), NREM sleep (E), or REM sleep (F) during 12-h light phase (Light),
12-h dark phase (Dark), and 24-h day (Total). Values are mean ± SEM. n = 6 for control, n = 4 for Nkx2.1-Bmal1−/− mice. *p < 0.05; **p < 0.01 by a Tukey-HSD
post-hoc. The p-values calculated by two-way repeated measures ANOVAs are: (A) the effect of genotype, F (1, 184) = 9.52, p = 0.015; the effect of time, F (23, 184) =
31.71, p < 0.001; and the interaction between genotype and time, F (23, 184) = 2.60, p < 0.001; (B) F (1, 184) = 5.94, p = 0.041; F (23, 184) = 29.30, p < 0.001;
F (23, 184) = 2.60, p < 0.001; (C) F (23,184) = 24.36, p < 0.001; F (23,184) = 2.26, p = 0.02; (D) the effect of genotype, F (1, 8) = 9.52, p = 0.015; the effect of time
(Light vs. Dark), F (1, 8) = 559.33, p < 0.001; and the interaction between genotype and time, F (1, 8) = 2.04, p = 0.191; (E) F (1, 8) = 5.94, p = 0.041; F (1, 8) =
567.63, p < 0.001; F (1, 8) = 4.17, p = 0.075; (F) F (1, 8) = 1.24, p = 0.299; F (1, 8) = 155.87, p < 0.001; F (1, 8) = 0.41, p = 0.538.
formation by local clocks in the hippocampus (Shimizu et al.,
2016), and Nakano et al., found that the same molecule
regulates the circadian expression of anxiety-like behavior
under the control of local clocks in the basolateral amygdala
(Nakano et al., 2016). On another front, Yu et al. reported
that Bmal1-dependent local clock in histaminergic neurons of
tuberomammillary nucleus (TMN) regulate sleep architecture,
likely via transcriptional control of the histidine decarboxylase
gene, which encodes a histamine-synthesizing enzyme, but
is not involved in regulating circadian rhythms (Yu et al.,
2014). Furthermore, Orozco-Solis et al. revealed that the
Bmal1-dependent local clock of VMH Sf1 neurons controls
circadian energy expenditure through the rhythmic activation
of BAT’s metabolism, yet plays little role in delineating
circadian activity and feeding rhythms (Orozco-Solis et al.,
2016).
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FIGURE 5 | Temporal pattern of food intake during the dark phase is altered in Nkx2.1-Bmal1−/− mice. (A) Hourly plots of food intake, expressed as
percentage of daily total. (B) Food intake per body weight during 12-h light phase (Light), 12-h dark phase (Dark), and 24-h day (Total). Values are mean ± SEM. n = 6
for control, n = 4 for Nkx2.1-Bmal1−/− mice. *p < 0.05; **p < 0.01; ***p < 0.001 by a Tukey-HSD post-hoc. The p-values calculated by two-way repeated measures
ANOVAs are: (A) the effect of genotype, F (1, 529) > 1000, p < 0.001; the effect of time, F (23, 529) = 53.22, p < 0.001; and the interaction between genotype and
time, F (23, 529) = 5.65, p < 0.001; (B) the effect of genotype, F (1, 23) = 0.003, p = 0.960; the effect of time (Light vs. Dark), F (1, 23) = 559.33, p < 0.001; and the
interaction between genotype and time, F (1, 23) = 2.04, p = 0.026.
It is notable that circadian rhythms of locomotor activity,
sleep-wakefulness, and food intake were all altered in parallel
in Nkx2.1-Cre mice. Hypothalamic areas originating from
Nkx2.1-positive neuroepithelium include several nuclei and
neurons implicated in the regulation of locomotor activity,
sleep-wakefulness, and feeding. For instance, orexinergic
neurons in the perifornical area and histaminergic neurons in
the TMN are wake-active and promote wakefulness, while a
population of GABAergic neurons in the POA is sleep-active
and increases sleep (Mieda and Sakurai, 2009; Saper et al., 2010).
The basal forebrain also contains multiple types of neurons that
control sleep-wakefulness (Saper et al., 2010; Xu et al., 2015).
The Arc, VMH, DMH, and LHA play important roles in the
regulation of feeding and energy metabolism (Gautron et al.,
2015). As mentioned previously, mice without Bmal1 specifically
in histaminergic or VMH Sf1 neurons showed phenotypes unlike
those of Nkx2.1-Bmal1−/− mice (Yu et al., 2014; Orozco-Solis
et al., 2016). Such observations suggest that Bmal1-dependent
local clocks in histaminergic or Sf1 neurons are not solely
responsible for altering nocturnal activity patterns in Nkx2.1-
Bmal1−/− mice. Orexinergic neurons may be well-placed to
regulate multiple rhythms consistently because these neurons
have been suggested to control locomotor activity, wakefulness,
and food intake cooperatively (Mieda and Sakurai, 2009).
Alternatively, multiple local brain clocks may differentially
fine-tune these three rhythms.
Although, Bmal1 is the sole non-redundant factor of cellular
clocks, the impairment caused by loss of Bmal1 may not
be necessarily due to disruption of clock function. Indeed,
several defects observed in standard Bmal1 knockout mice,
such as reduced life span, fertility, and body weight, were not
detected in inducible Bmal1 knockout mice that expressed the
gene during embryogenesis but not after birth (Yang et al.,
2016). Because Nkx2.1 is expressed in the neuroepithelium
during embryogenesis, the possibility that the impairments
of circadian rhythms in Nkx2.1-Bmal1−/− might reflect the
function of Bmal1 unrelated to the cellular clock cannot be
excluded.
In conclusion, we demonstrated that Bmal1-dependent
circadian clocks in the SCN and extra-SCN brain regions
cooperate to delineate the precise daily patterns of locomotor
activity, sleep-wakefulness, and food intake. However, the
location of relevant local clocks remains unidentified and thus
a task for future research.
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